Howard Feldman, the Executive Associate Dean, Research and a Professor of Neurology in the Faculty of Medicine, was interviewed by the CBC on Dec. 12 while attending the G8 Dementia Summit in London, U.K.
Dr. Feldman was attending as a member of the Canadian delegation. Other members include the Hon. Rona Ambrose, the federal Minister of Health, and Alain Beaudet, president of the Canadian Institutes of Health Research.
Dr. Feldman was formerly the Head of the Division of Neurology and the Director of the Clinic for Alzheimer Disease and Related Disorders at UBC Hospital. In 2007, he was appointed the inaugural Fisher Family and Alzheimer Society of British Columbia Endowed Professor for Research in Alzheimer’s Disease.
In January 2009, Dr. Feldman took a leave from his academic appointments to take on the role of Vice President and Therapeutic Area Head in Neuroscience, Global Clinical Research and Development at Bristol-Myers Squibb. In this role, he led research and development of novel pharmaceutical therapies for neurological and psychiatric conditions at the company’s laboratories in Connecticut.